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ABSTRACT
XRCC4 and XLF are structurally related proteins im-
portant for DNA Ligase IV function. XRCC4 forms a
tight complex with DNA Ligase IV while XLF inter-
acts directly with XRCC4. Both XRCC4 and XLF form
homodimers that can polymerize as heterotypic fila-
ments independently of DNA Ligase IV. Emerging
structural and in vitro biochemical data suggest
that XRCC4 and XLF together generate a filament-
ous structure that promotes bridging between DNA
molecules. Here, we show that ablating XRCC4’s
affinity for XLF results in DNA repair deficits
including a surprising deficit in VDJ coding, but
not signal end joining. These data are consistent
with a model whereby XRCC4/XLF complexes hold
DNA ends together—stringently required for coding
end joining, but dispensable for signal end joining.
Finally, DNA-PK phosphorylation of XRCC4/XLF
complexes disrupt DNA bridging in vitro, suggesting
a regulatory role for DNA-PK’s phosphorylation of
XRCC4/XLF complexes.
INTRODUCTION
Developing lymphocytes usurp the ubiquitously expressed
‘classical’ non-homologous end joining (c-NHEJ)
pathway to resolve DNA double-strand breaks (DSBs)
introduced by the RAG endonuclease during the process
of VDJ recombination that assembles functional
antigen-binding receptor genes from component gene
segments (1). The RAG complex introduces DSBs imme-
diately adjacent to immune receptor gene segments result-
ing in blunt phosphorylated signal ends and covalently
sealed hair-pinned coding termini which are joined by
c-NHEJ (2). Coding and signal ends are joined at very
different rates, rapid for coding ends while slower for
signal ends (3). This is likely explained by the fact that
the RAG complex remains tightly associated with signal
ends after cleavage in a post cleavage complex, whereas
coding ends are released from this post cleavage complex
and need to be brought together again for repair (4).
Seven c-NHEJ components are required for VDJ
recombination: Artemis, KU70, KU86, DNA-PKcs,
XRCC4, XLF and DNA Ligase IV (5). Although all
seven are required for efﬁcient coding end joining, the
dependence of signal end joining on these c-NHEJ
factors is less absolute. Artemis is not required for signal
end joining; a reﬂection of its speciﬁc role in opening the
sealed hair-pinned termini of cleaved coding ends (6). The
dependence of signal end joining on DNA-PKcs is
variable. Artemis’s endonuclease activity requires
physical interaction with DNA-PKcs as well as
DNA-PK’s enzymatic activity. Because Artemis is dis-
pensable for signal end joining it is reasonable to assume
that signal end joining might also progress normally in the
absence of DNA-PKcs (6). Indeed, signal end joining
proceeds fairly efﬁciently in developing murine lympho-
cytes ( 10–50% of wild-type levels) and in some murine
and one human cell line deﬁcient in DNA-PKcs (7,8).
However, DNA-PKcs deﬁciency in other species
(hamster, horse, dog) results in a more severe reduction
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The RAG complex (and possibly other factors) may help
maintain synapsis of signal ends if other factors important
for synapsis (like DNA-PKcs or other non-core NHEJ
factors that may vary in expression levels in different
cell lines or species) are lacking or limiting, perhaps par-
tially explaining the variable asymmetry of effects on
coding versus signal end joining in the absence of
DNA-PKcs. Although the severity of VDJ deﬁcits differs
in cells deﬁcient in any of the other ﬁve core c-NHEJ
components [XLF<KU protein<XRCC4 or DNA
Ligase IV], the relative effect on signal versus coding
end joining is similar in each (12). In contrast, cells deﬁ-
cient in factors that clearly promote c-NHEJ, but are not
absolutely required for c-NHEJ (ATM, MRN, 53BP1)
have only modest VDJ recombination deﬁcits which are
remarkably speciﬁc to coding end resolution (13–15);
it has been suggested that the function of ATM (and
perhaps other factors upstream or downstream of ATM)
in c-NHEJ is to promote bridging of DNA ends.
Thus, an emerging consensus suggests that asymmetry
of coding and signal end joining is a reﬂection not only of
a requirement to open hair-pinned coding ends, but also
on a more stringent requirement for synapsis (by repair
machinery) to promote efﬁcient coding end joining.
Moreover, the variability in the proﬁciency of signal end
joining in different DNA-PKcs deﬁcient cell lines and
species might be explained by a more efﬁcient ability to
maintain synapsis of signal ends in the absence of
DNA-PKcs in certain species and or cell lines (16,17).
XLF, the most recently discovered c-NHEJ factor inter-
acts with the DNA Ligase IV complex via direct inter-
action with XRCC4 (18,19). A complex of XRCC4,
XLF and DNA Ligase IV performs the ﬁnal ligation
step in classical NHEJ. Although XRCC4 and XLF
share little primary sequence homology, secondary struc-
ture predictions and later crystallographic analyses
demonstrated that XLF and XRCC4 are structurally
highly related (20,21). Both XRCC4 and XLF form
stable homodimers that can associate to form XLF/
XRCC4 oligomers (22). Both also bind DNA in a
sequence non-speciﬁc and concentration-dependent
manner with higher afﬁnities as the length of the DNA
substrate is increased (23,24). XRCC4’s interaction with
Ligase IV precludes XRCC4 homo-tetramerization
(22,25,26). One DNA Ligase IV molecule interacts with
the tail region of one XRCC4 dimer and XLF interacts
with XRCC4 but not DNA Ligase IV (26–29). XLF inter-
acts with this complex directly through the XRCC4
N-terminal head domain (21). XLF stimulates ligation
of non-cohesive DNA ends, promotes the readenylation
of DNA Ligase IV, and gap ﬁlling by polm and pol  
(30–32). Unlike the role of XRCC4 in promoting Ligase
IV function which is at least partially understood, the
mechanistic basis of how XLF functions to promote
DNA Ligase IV’s function is largely unknown.
Mutational analysis has revealed a potential interaction
interface between XRCC4 and XLF involving the head
domains of both molecules (21). These data suggest a
stacked head to head interaction between XLF and
XRCC4. Small Angle X-Ray Scattering analyses and
new crystallographic data (22,33–37) deﬁne XRCC4/
XLF ﬁlaments that form via the head to head interaction
of XRCC4 and XLF; in vitro, these XRCC4/XLF
complexes promote bridging between DNA molecules.
Here, we characterize the functional consequence in
living cells of ablating XRCC4’s interaction with XLF.
Additionally, we explore (both in vitro and in living
cells) the functional consequence of DNA-PK phosphor-
ylation of XRCC4/XLF complexes.
MATERIALS AND METHODS
Plasmids and cell strains
Wild-type and mutant XLF and XRCC4 cDNAs were
cloned into the pEF plasmid that provides expression by
the EF1a promoter and also contains the neomycin resist-
ance gene (Invitrogen, Carlsbad, CA, USA). Cell lines
utilized in this study include the CHO mutant cell line
XR-1 that lacks XRCC4 expression [generous gift of
Tom Stamato], wild-type CHO cell line AA8, and
Phoenix HEK293 cells [generous gift of Dr Justin
McCormick]. XR-1 cells were maintained in aMEM
(Gibco; Carlsbad, CA, USA) supplemented with 10%
fetal bovine serum or supplemented calf serum and
100U/ml penicillin, 100mg/ml streptomycin. XR-1 cells
stably expressing wild-type and mutant forms of human
XRCC4 were maintained in above media containing
800mg/ml G418. Stable transfectants coexpressing
XRCC4 and GFP tagged DNA-PKcs were maintained
in above medium along with 800mg/ml G418 and 5mg/ml
blasticidin.
Cell transfections
Ten micrograms of pEF plasmid DNA expressing
wild-type or mutant XRCC4 were linearized by PvuI re-
striction and transfected into XR-1 or AA8 cells.
Transfections were performed in 60mm diameter dishes
with the Fugene6 transfection reagent (Roche Molecular
Biochemicals; Indianapolis, IN) according to the manu-
facturer’s protocol. Forty-eight hours after transfection,
cells were plated into selection media containing
1600mg/ml G418. Independently isolated clones were
screened for XRCC4 expression by immunoblot analysis.
XR-1 transfectants expressing wild-type or 9Xala
murine XRCC4 have been described previously (38).
XLF expression vectors encoding wild-type or 6Xala
XLF have been described previously (39). To over-express
wild-type or 6Xala XLF in XR-1 cells expressing the
9Xala XRCC4 mutant, 40mg expression plasmid was
transfected into the 9Xala transfectant as described
above. Forty-eight hours later cells were placed under
hygromycin (400mg/ml) selection and stable clones
isolated as described above. XLF expression was
assessed by immunoblotting.
Immunoblot analyses
Antibodies utilized in this study include a polyclonal
rabbit anti-XRCC4 reagent (Abcam; Cambridge,
MA, USA), a polyclonal anti-XLF reagent (Abcam),
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USA) and phosphospeciﬁc antibodies to pS260 and
pS318 in XRCC4, raised in sheep against the following
phosphopeptides: Ser
260: SIISSLDVTD and Ser
318: AEN
MSLETLR (phosphoserines underlined). Phosphospeciﬁc
antibodies were afﬁnity puriﬁed as described previ-
ously (40). Phospho-speciﬁc reagents were characterized
using site-speciﬁc XRCC4 mutant proteins described
previously (38).
Whole-cell extracts were obtained by re-suspending cell
pellets in solubilization buffer containing 50mM HEPES
(pH 7.5), 150mM NaCl, 0.1% Triton X-100, 5mM man-
ganese chloride, 50mM sodium ﬂuoride, 2mg/ml DNAase
I and protease inhibitor cocktail (Roche Molecular Bio-
chemicals; Indianapolis, IN, USA). For human XRCC4
or human XLF transfectants, 25mg of each cell extract
was electrophoresed on an 8% SDS–PAGE gel and
transferred to PVDF membranes. Membranes were
probed with either rabbit polyclonal antibody to XRC
C4 or XLF. For murine XRCC4 (or 9Xala XRCC4)
transfectants, a monoclonal V5 antibody was used as the
primary antibody. Anti-rabbit or anti-mouse HRP were
used as secondary antibodies and membranes were
exposed to chemiluminescent substrate to visualize
XRCC4 or XLF.
VDJ recombination assays
Extrachromosomal VDJ recombination assays were per-
formed utilizing a coding joint substrate [pJH290] and
signal joint substrate [pJH201] as described previously
(41). Brieﬂy, XR-1 cells were transiently transfected with
1mg substrate, 3mg wild-type or mutant forms of XRCC4
or pEF1 vector, and 3mg each of RAG1 and RAG2 using
the Fugene6 transfection reagent. Forty-eight hours after
transfection, substrate plasmids were isolated by alkaline
lysis and subjected to DpnI digestion for 1h. DpnI-
digested DNA was transformed into competent DH5a
cells (Invitrogen; Carlsbad, CA, USA) according to manu-
facturers’ instructions. Transformed cells were spread
onto LB Agar plates containing 100mg/ml ampicillin
only or with 100mg/ml ampicillin and 22mg/ml
chloramphenicol.
Assessment of radiosensitivity and drug sensitivities
To determine sensitivity to ionizing radiation (IR), 4000
cells from each of the XRCC4 wild-type and mutant
clones were harvested and treated with various doses of
IR in serum free media, using a
60Co source. Immediately
after irradiation, cells were plated back into 100cm
2 dishes
containing aMEM supplemented with 10% FBS. For
zeocin resistance assays, 100 cells of each AA8 or XR-1
transfectant were plated in 60cm
2 dishes containing the
appropriate culture media (without selection agents)
supplemented with the indicated doses of zeocin. After
7 days, colonies were ﬁxed and stained with crystal
violet to establish relative survival.
DNA bridging assay
The DNA bridging assay is described by Andres et al.
(35). The one-end biotinylated 1000bp DNA substrate
was prepared by PCR using Phusion DNA polymer-
ase, primers: 50-Biotin GAGTTTTATCGCTTCCAT
GAC and 50-AATTTATCCTCAAGTAAGGGGC and
PhiX174 DNA as template. The 500bp DNA substrate
was similarly prepared using primers 50-GAGTTTTATC
GCTTCCATGAC and 50-CAGAAAATCGAAATCATC
TTC. PCR products were puriﬁed by agarose gel elec-
trophoresis and QIAquick Gel Extraction Kit
(QIAGEN) and stored in 10mM Tris pH 8, 1mM
EDTA. Magnetic streptavidin-coated beads (Dynabeads
M-280 Streptavidin, Invitrogen) were ﬁrst passivated by
washing the bead suspension three times with one volume
of binding buffer (20mM HEPES pH 8, 75mM KCl,
0.5mM EDTA, 1mM DTT, 5% glycerol, 400mg/ml
acetylated BSA) and ﬁnally resuspended in the same
volume of binding buffer. For each reaction, 200ng of
end biotinylated 1000bp DNA were added to 10mlo f
passivated bead suspension and incubated for 5min at
room temperature (>90% attachment). Next, 200ng of
500bp DNA fragment were added before addition of the
XRCC4, XLF (each at 2mM) in a total volume of 40mli n
binding buffer supplemented with 1mM ATP and 2mM
MgCl2. After 5min incubation at room temperature,
puriﬁed DNA-PK (Promega) was added and the
reaction mixtures were incubated for 30min at room tem-
perature after which beads were collected with the magnet
without any centrifugation step. The 40ml supernatant
fractions were analyzed by electromobility shift assay by
electrophoresis in 0.8% agarose gel in Tris–borate buffer.
The beads were washed two times with one volume of
binding buffer and ﬁnally resuspended in 40mlo f
binding buffer without BSA. Proteinase K (40mg) and
Sarkosyl (0.5% ﬁnal) were added to the bead suspension,
incubated for 30min at 50 C and resolved by electrophor-
esis in 0.8% agarose gel in Tris–borate buffer.
Assessment of XRCC4 phosphorylation by DNA-PK
XRCC4, XLF, and the BRCT domains of DNA Ligase IV
were expressed in bacteria and isolated via Ni
2+ agarose
afﬁnity as described previously (21). DNA-PK was
purchased from Promega (Madison, WI, USA). Proteins
(DNA-PK 20U, XRCC4 2mg, XLF 2mg, BRCT 1mg)
were incubated for 60min at room temperature in kinase
active conditions [50mM HEPES (pH 7.5); 100mM KCl;
10mM MgCl2; 0.2mM EGTA; 0.1mM EDTA; 1mM
DTT; 20mg/ml calf thymus DNA; 0.1mM ATP].
Reactions were stopped by the addition of SDS-loading
buffer and analyzed either by phosphorimaging or
immunoblotting.
RESULTS
XRCC4 mutants that do not interact with XLF restore
signal, but not coding end joining in XRCC4-deﬁcient cells
To characterize how XRCC4 and XLF interact, we previ-
ously mutated highly conserved XRCC4 residues not pre-
dicted to be involved in either dimerization or in DNA
Ligase IV interaction (21). Of 17 point or combined
XRCC4 mutants, 7 displayed a similar defect in their
ability to interact with XLF implicating a cluster of
1686 Nucleic Acids Research, 2012,Vol.40, No. 4residues (K63, K65 and K99) at the base of the head as
being important for XRCC4’s interaction with XLF.
Mutation of these residues resulted in XRCC4 molecules
that preserved full DNA Ligase IV binding, but abolished
interaction with XLF.
To assess the relevance of XRCC4’s interaction
with XLF in living cells, eight XRCC4 mutants that
interact with DNA Ligase IV analogous to wild-type
XRCC4, but are markedly defective in their ability to
interact with XLF (21), were tested for their ability to
support VDJ recombination in XRCC4 deﬁcient CHO
cells (XR-1). Previous studies place these residues in the
head region of XRCC4 (Figure 1A); the protein–protein
interface (top panel, Figure 1A) has been determined
(33–37). A useful method to study VDJ recombination
is to assess recombination of plasmid substrates intro-
duced into cultured cells (‘the Gellert assay’) (41).
Whereas wild-type XRCC4 and all eight mutants restore
similar levels of recombination when assessing signal
joints (left panel), only minimal levels of coding joints
(right panel) are supported by any of these eight
mutants (Figure 1B).
Although all eight mutants display clear deﬁcits in the
level of coding end resolution, both support a low level of
coding end joining, perhaps analogous to ‘leaky’ joining
observed in cells deﬁcient in Artemis or DNA-PKcs and to
a much lower extent in cells deﬁcient in either component
of the Ku heterodimer, XRCC4, or DNA Ligase IV.
Well-known characteristics of ‘leaky’ joining, mediated
by the a-NHEJ pathway include excessive nucleotide
loss, long P elements or extensive use of short sequence
homologies. In contrast, successful coding and signal
joints formed in the absence of XLF are indistinguishable
from those formed in wild-type cells (42,43). To address
whether joining mediated by the XRCC4 mutants is
analogous to leaky SCID joining, coding joints were
sequenced; coding joints mediated by XRCC4 mutants
46 and 48 are indistinguishable from those mediated by
wild-type XRCC4 (Table 1). Similarly, signal joints
isolated from VDJ assays in cells expressing mutants
46 and 48 displayed 100% ﬁdelity and 95% ﬁdelity
respectively, unlike those isolated from cells completely
deﬁcient in XRCC4, DNA-PKcs or other c-NHEJ com-
ponents. These data imply that although the coding end
Figure 1. XRCC4 mutants that do not interact with XLF partially restore c-NHEJ deﬁcits in XRCC4 deﬁcient cells. (A) Depiction of the region
harboring mutations in XRCC4 that result in disruption of its ability to interact with XLF. (B) Percentage recombination of signal joint substrate
(pJH201, left panel) or coding joint substrate (pJH290, right panel) in XR-1 cells transiently expressing wild-type RAGs and wild-type, mutant
(46,48), or no XRCC4. Error bars indicate SEM. (C) Immunoblot analysis (25mg WCE/lane) of XR-1 transfectants expressing wild-type (wt) or
mutant (46,48) XRCC4 using a polyclonal rabbit anti-human XRCC4 primary antibody. (D) Radioresistance of XR-1 cells expressing wild-type (wt),
mutant (46,48), or no (vector) XRCC4. Error bars indicate SEM.
Nucleic Acids Research,2012, Vol.40, No. 4 1687joining rate is diminished, successful joining mediated by
XRCC4 mutants 46 and 48 likely proceed by a c-NHEJ
mechanism, similar to joints formed in the absence of
XLF (42,43).
XRCC4 mutants that do not interact with XLF only
partially restore radioresistance in XRCC4 deﬁcient cells
We next stably expressed wild-type and mutant XRCC4
in the XR-1 cell strain (Figure 1C), and assessed
radiosensitivity. Whereas wild-type human XRCC4
substantially reverses radiosensitivity of XR-1 cells
(Figure 1D), both XRCC4 mutants only partially
reversed radiosensitivity. We conclude that XRCC4’s
ability to interact with XLF is functionally important
for its role in repairing ionizing radiation induced
DNA damage. Moreover, the more pronounced effect
on coding (versus signal) end joining observed is
somewhat reminiscent of the c-NHEJ phenotypes
observed in ATM or MRN deﬁcient cells that have been
tentatively attributed to inefﬁcient end synapsis (13–15).
These similarities to the ATM/MRN phenotypes coupled
with emerging structural data of a stable XRCC4/XLF
ﬁlament (33–37) suggest a previously unidentiﬁed
function of XRCC4/XLF complexes in promoting DNA
end synapsis.
Over expression of XRCC4 mutants that do not interact
with XLF radiosensitizes wild-type CHO cells
Data presented thus far and emerging structural data
(33,35–37) are consistent with a model whereby XLF/
XRCC4 complexes promote synapsis or stability of
DNA ends in the repair complex. However, it seems
unlikely that this DNA bridging function is strictly
required for the c-NHEJ reaction since signal end
joining does not require the XRCC4/XLF interaction. It
follows that XRCC4/DNA Ligase IV complexes are
capable of functioning (without XLF) in the c-NHEJ
reaction. To address whether the XRCC4/DNA Ligase
IV complex normally functions independently of
XRCC4/XLF complexes, or alternatively if DNA Ligase
IV is included in XRCC4/XLF complexes (the DNA
Ligase IV and XLF interaction regions in XRCC4 are
distinct), we tested whether XRCC4 mutants that cannot
interact with XLF could exert a dominant negative effect
in wild-type cells. If XRCC4/XLF complexes and
XRCC4/DNA Ligase IV complexes act independently,
over-expression of the mutants (which should sequester
endogenous DNA Ligase IV) should not interfere
with endogenous XRCC4/XLF complexes. However, if
DNA Ligase IV functions as part of a potential
XRCC4/XLF DNA ‘bridging’ complex, over-expression
of the XRCC4 mutants (and sequestration of all endogen-
ous DNA Ligase IV to mutant XRCC4 complexes)
should result in dominant negative inhibition. Over-
expression of XRCC4 mutants 46 and 48, but not wild-
type human XRCC4 modestly sensitizes the wild-type
CHO cell line AA8 to the radiomimetic drug zeocin
(Figure 2). This is not a complete block in c-NHEJ
activity because neither coding nor signal end joining
are signiﬁcantly inhibited by coexpression of these
XRCC4 mutants (data not shown). Although other
explanations are possible, these data suggest a functional
requirement for DNA Ligase IV occupancy in XRCC4/
XLF complexes.
Figure 2. Over-expression of XRCC4 mutants that do not interact with
XLF radiosensitizes wild-type CHO cells. (A) Immunoblot analysis
(30mg WCE/lane) of AA8 cells stably expressing wild-type or mutant
XRCC4 using a polyclonal rabbit anti-human XRCC4 primary
antibody. As can be seen, endogenous hamster XRCC4 is detected in
the vector only transfectant (B) Zeocin resistance of AA8 cells
over-expressing wild-type or mutant XRCC4 as indicated. Error bars
indicate SEM.
Table 1. Normal end processing of coding and signal joints mediated by XRCC4 mutants that do not interact
with XLF
Coding joints Signal joints
No. of joints
sequenced
Nucleotide
loss/joint
Percent
utilizing SSH
No. of Joints
Sequenced
Percent
perfect
Wild-type XRCC4 46 3.7 45 40 100
Mutant 46 K65E, K99E 35 4.0 45 38 100
Mutant 48 K72E, K90E, K99E 46 4.7 32 39 94.9
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with XLF but not when bound to DNA Ligase IV
XRCC4 and XLF are both robustly targeted by
DNA-PK’s enzymatic activity in vitro and in vivo (39,44).
Although no functional relevance has been ascribed to
XLF or XRCC4 phosphorylations (38,39,44), we con-
sidered that different XRCC4 complexes might be
targeted by DNA-PK’s enzymatic activity differently. To
assess phosphorylation of XRCC4/XLF/DNA Ligase IV
complexes by DNA-PK, wild-type and mutant XRCC4 as
well as XLF and a fragment of DNA Ligase IV encoding
the two tandem BRCT domains (BRCTs) were puriﬁed
from bacteria and used as substrates in kinase assays.
Wild-type XRCC4 (but not mutant 46) promotes phos-
phorylation of XLF, and XLF promotes phosphorylation
of wild-type XRCC4 (but not mutant 46) (Figure 3A,
compare lanes 2, 5, 6, 9 and 10). The enhanced phosphor-
ylation of XRCC4 in the presence of XLF is appreciated
not only as increased incorporation of phosphorous-32,
but also as marked decrease in mobility of a fraction
of the phosphorylated XRCC4, representing hyper-
phosphorylated XRCC4 (lane 6). XRCC4 can be
phosphorylated on multiple sites, with S260 and S318
being the most prominent sites; S193, S302, S313, T321,
S325 and S326 can also be phosphorylated (38). As
expected, the effect of enhanced XRCC4 and XLF phos-
phorylation is not observed with XRCC4 mutant 46 since
it does not interact with XLF (compare lanes 5, 6, 9 and
10). In contrast, although the addition of BRCTs clearly
enhances phosphorylation of XRCC4, the phosphoryl-
ations seem to be less complex because the change in elec-
trophoretic mobility is strongly suppressed (lane 7). As
expected, the BRCT domain fragment has a similar
effect on phosphorylation of mutant 46 since this
mutant interacts with DNA Ligase IV as well as
wild-type XRCC4 (compare lanes 9 and 11).
Two phospho-speciﬁc reagents (anti-pS260 and
anti-pS318) were developed. Validation of the speciﬁcity
of these reagents was veriﬁed (Figure 3B) using S260A and
S318A XRCC4 mutants described previously (38). These
reagents were used to assess the effect of XLF and BRCT
domains on XRCC4 phosphorylation by DNA-PK
in vitro. Whereas phosphorylation of S260 is enhanced
in wild-type XRCC4 by XLF, this is not observed in
mutant 46 (Figure 3C). Moreover, the BRCT fragment
of DNA Ligase IV inhibits S260 phosphorylation. In
contrast, although S318 is clearly phosphorylated by
DNA-PK (no S318 phosphorylation is detected in the
absence of DNA-PK, Figure 3C, lane 1), neither XLF
nor the BRCT fragment of DNA Ligase IV dramatically
affects S318 phosphorylation. We conclude that this site is
targeted efﬁciently by DNA-PK whether uncomplexed or
complexed with either XLF or the BRCT domain of ligase
IV. We conclude that XLF promotes phosphorylation of
XRCC4 on S260 and likely other sites as well. In contrast,
BRCTs promotes XRCC4 phosphorylation, but not at
either S318 or S260. Moreover, BRCTs inhibit XRCC4’s
hyper-phosphorylation. These data demonstrate that
phosphorylation of XRCC4 by DNA-PK varies depend-
ing on whether XRCC4 is complexed with XLF or
BRCTs.
DNA-PK phosphorylation disrupts DNA bridging in vitro
In the accompanying manuscript, data is presented
demonstrating that XRCC4/XLF ﬁlaments bridge DNA
molecules in vitro. Brieﬂy, an assay was developed to
assess bridging of two DNA molecules by recombinant
proteins. In this assay, one DNA is biotin labeled and
can be immobilized onto streptavidin beads. If bridging
occurs (by protein–DNA interaction), the second DNA
(different size) will be ‘pulled down’ onto the streptavidin
beads. DNA–protein interactions can be visualized con-
currently by electrophoresis of the supernatant fraction. In
Figure 4A, the effect of DNA-PK phosphorylation on
XRCC4/XLF’s ﬁlaments ability to bridge DNA was
assessed. Consistent with data presented by Andres et al.
(35), DNA bound XRCC4/XLF multimers are observed
by EMSA (left panel, lane 4) and the DNA ‘bridged’ by
XLF/XRCC4 multimers is recovered on beads (right
panel, lane 4). However, in the presence of DNA-PK,
Figure 3. XRCC4 can be hyper-phosphorylated when in complex with
XLF but not when bound to DNA Ligase IV. (A) Phosphorimaging of
SDS–PAGE analyses of in vitro kinase assays including DNA-PK,
wild-type or mutant XRCC4, wild-type XLF, and the BRCT
domains of DNA Ligase IV (BRCTs). (B) Puriﬁed wt, S260A or
S318A XRCC4 (1mg) was incubated with DNA-PK under standard
assay conditions either in the absence (lane 1) or presence of 10mg/
ml sonicated calf thymus DNA. Reactions analyzed by immunoblotting
with phosphospeciﬁc antibodies to serine 260 or serine 318, or total
XRCC4. (C) Immunoblotting analyses (top panel and middle panel) of
in vitro kinase assays including DNA-PK, wild-type or mutant XRCC4,
wild-type XLF, and the BRCT domains of DNA Ligase IV using
phospho-speciﬁc antibodies that recognize XRCC4 pS260 (top panel)
or XRCC4 pS318 (middle panel). Bottom panel is phosphor image of
immunoblot to detect P-32 incorporation in experiment presented in
top and middle panels.
Nucleic Acids Research,2012, Vol.40, No. 4 1689only the XLF/DNA complex is apparent by EMSA, and
we conclude that DNA-PK phosphorylations result in dis-
sociation of XRCC4 from XLF bound DNA. Moreover,
DNA bridging is similarly disrupted (right panel, lanes
5–7) reinforcing conclusions of Andres et al. (35) that
DNA bridging is accomplished by DNA-bound XLF/
XRCC4 multimers. In sum, these data suggest that
XRCC4/XLF multimer stability and DNA bridging are
disrupted by DNA-PK phosphorylation.
DNA-PK phosphorylation of the many sites in the
C-terminal tails of XLF and XRCC4 are functionally
redundant; blocking XRCC4/XLF phosphorylation results
in increased cell survival after DNA damage
Considerable effort from our laboratories has focused on
determining the functional relevance of DNA-PK targets,
including phosphorylations of both XRCC4 and XLF
(38,39). Previous mutational analysis of six sites in XLF
and nine sites in XRCC4 suggest that these phosphoryl-
ations are not critical for c-NHEJ. Phosphorylations of
both molecules occur in living cells in the C-terminal
ﬂexible tail domains (not present in crystallographic struc-
tures). Modeling and mutational studies suggest that the
C-termini of both XRCC4 and XLF may be important for
both ﬁlament stability and its interaction with DNA
(35,36). We considered that the phosphorylation-induced
multimer disruption observed in vitro (Figure 4A) might
be accomplished by phosphorylating the C-termini of
either XRCC4 or XLF. To test this possibility, expression
constructs encoding wild-type or a mutant XLF with six
alanine substitutions of sites in the XLF C-terminus
were stably transfected into an XR-1 transfectant that
expressed murine XRCC4 with nine alanine substitutions
of XRCC4’s conserved phosphorylation sites. Over-
expression of the 6A XLF mutant markedly protects the
9A XRCC4 transfectant from zeocin induced DNA
damage (Figure 4C); this is not just a consequence of
XLF over-expression since wild-type XLF expressed in
the same cell strain at similar levels does not signiﬁ-
cantly alter zeocin resistance in XR-1 cells expressing
the 9A mutant. We conclude that phosphorylations of
XRCC4 and XLF are functionally relevant, but
Figure 4. DNA-PK phosphorylation of the many sites in the C terminal tails of XLF and XRCC4 are functionally redundant with each other and
facilitate ﬁlament dissociation. (A) Proteins were incubated with streptavidin-coated magnetic beads linked to a biotinylated 1000bp DNA and free
500bp DNA. Beads were separated from supernatant and analyzed separately for presence of the 500bp DNA. An amount of 200ng each of 1000
and 500bp DNA fragments were incubated with XRCC4 (2mM) and/or XLF (2mM) and 0, 111, 222 or 333 units of DNA-PK in lanes 4 to 8,
respectively. Left panel shows protein–DNA complexes in the supernatants by EMSA. Right panel shows the recovery of DNA species on the beads.
(B) Immunoblot analysis (25mg WCE/lane) of XR-1 transfectants expressing wild-type (wt), vector (vect), or 9X ala mutant V5 tagged murine
XRCC4 (9A), or the 9Xala mutant in addition to wild-type XLF (wt) or 6X ala mutant human XLF (6A). A monoclonal V5 primary antibody was
used to detect murine XRCC4; a polyclonal rabbit anti-human XLF reagent was used to detect XLF. (C) Radioresistance of XR-1 cells expressing
wild-type (wt), vector (vect), or 9X ala mutant XRCC4 (9A), or the 9Xala mutant in addition to wild-type XLF (wt) or 6X ala mutant XLF (6A).
Error bars indicate SEM.
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ation promotes cell survival after zeocin-induced DNA
damage
DISCUSSION
VDJ coding end resolution is highly dependent on
XRCC4/XLF ﬁlaments
A wide variety of XRCC4 mutants have been studied pre-
viously, and in all cases mutants that fail to complement
the radiosensitivity of XRCC4-deﬁcient cells also have
deﬁcits in both signal and coding end joining. Although
the observation of an XRCC4 mutation that results in an
asymmetric loss in VDJ intermediate resolution is unex-
pected, asymmetric loss of coding (but not signal) end
joining is well appreciated for two other c-NHEJ factors
(Artemis and DNA-PKcs) as well as in an emerging group
of non-‘core’ c-NHEJ factors (ATM, MRN, 53BP1) that
appear to facilitate coding end synapsis during c-NHEJ
(13–15). The asymmetry in coding and signal end reso-
lution in cells lacking Artemis is readily explained by its
unique role in opening the hair-pinned termini of cleaved
coding ends. The dependence of DNA-PKcs on signal end
joining is also variable. Since the assembled DNA-PK
complex is fully capable of synapsing DNA ends, it
seems possible that DNA-PKcs may also participate in
end synapsis, and that variability in signal end joining in
different DNA-PKcs deﬁcient cells may be explained by
compensation (or lack of compensation) by other factors
that can facilitate synapsis. A prevailing consensus has
emerged regarding the non-essential role of non-core
factors (ATM, MRN, 53BP1); recent reports suggest
that these factors facilitate DNA end bridging during
c-NHEJ. Thus, defects in these factors impact coding
end joining (but not signal end joining) and long-range
VDJ joins are more severely affected than proximal VDJ
joints. Moreover, Alt and colleagues (45) have demon-
strated functional redundancy between either ATM or
H2AX and XLF, and have thus added XLF to the list
of factors that may facilitate DNA end bridging during
c-NHEJ. It is only using the separation-of-function
mutants described here that XRCC4’s function as a
bridging factor (in complex with XLF) is revealed, since
XRCC4’s function as DNA Ligase IV’s cellular cofactor is
essential for c-NHEJ.
Phosphorylation of XRCC4 and XLF is functionally
redundant and disrupts XRCC4/XLF ﬁlaments
Considerable effort has focused on deﬁning relevant
targets of DNA-PK’s robust catalytic activity; numerous
studies have deﬁned numerous in vitro and in vivo
DNA-PK target sites. Until this study, autophos-
phorylations within DNA-PKcs were the only phosphor-
ylations shown to be unequivocally relevant for c-NHEJ
[reviewed in (46)]. Here, we demonstrate that phosphoryl-
ations of the C-termini of XRCC4 and XLF are functional
relevant but functionally redundant. Although blocking
either XRCC4 or XLF phosphorylation does not affect
resistance to ionizing radiation or radio-mimetic drugs,
blocking phosphorylation of both XLF and XRCC4
results in enhanced cell survival after zeocin-induced
DNA damage. These data coupled with in vitro analysis
of DNA-PK’s effect on XRCC4/XLF complexes suggest
that blocking XRCC4 and XLF phosphorylation stabil-
izes XRCC4/XLF ﬁlaments, promoting repair by
c-NHEJ. Although other explanations are possible, we
hypothesize that DNA-PK phosphorylation of XRCC4/
XLF complexes or ﬁlaments might function to promote
either transition to a ligase active complex or to promote
complex dissociation.
Redundancy is an emerging theme for DNA-PK
targets. Autophosphorylation of DNA-PKcs occurs on
many sites, is functionally complex, and functionally re-
dundant. For several different (phosphorylation modu-
lated) functions, different sites within DNA-PKcs can be
phosphorylated to promote the same function (46). The
importance of phosphorylation site redundancy in DSB
repair is underscored by recent work showing that pro-
gressive ablation of 28 distinct ATM/ATR/DNA-PK
targets in 53BP1 progressively disrupts function (47).
Do XRCC4/XLF/DNA Ligase IV complexes function as
part of larger XRCC4/XLF ﬁlaments?
Recent structural studies of XRCC4/XLF ﬁlaments
(33,35–37) provide the molecular basis for earlier observa-
tions of higher order XRCC4 and XLF multimers (22,48).
It is intriguing to speculate that these ﬁlaments span DNA
ends and that perhaps the XRCC4/DNA Ligase IV
complex only associates with XRCC4-XLF ﬁlaments at
the site of damage. Although other interpretations are
possible, the fact that XRCC4 mutants that cannot
interact with XLF exert a modest dominant negative
effect in wild-type cells is consistent with the conclusion
that DNA Ligase IV is targeted to DNA ends through its
interaction with XRCC4, which is itself part of a larger
XRCC4/XLF DNA ‘bridging’ complex that functions to
provide stabilization of the DNA termini during repair.
An early role for XRCC4/XLF in c-NHEJ
From the ﬁndings presented here ascribing XRCC4/XLF
complexes to an early step in c-NHEJ, a new model for
c-NHEJ emerges (Figure 5). Chen and colleagues (49–51)
have shown that XLF is directed to sites of DNA damage
by its interaction with Ku (pink/maroon); thus, XRCC4/
XLF ﬁlaments (dark blue) may be targeted to DSBs via
DNA-bound-Ku, functioning to keep broken DNA ends
in the same proximity. A single XRCC4/XLF ﬁlament
bundle [as modeled by Andres et al. (35)] is shown in
grey (second panel); in their studies multiple ﬁlament
bundles facilitate parallel bridging of DNA molecules
(not illustrated here). The ability of XRCC4/XLF to
nucleate into these higher order ﬁlaments could not only
be important in bridging two DNA ends at a single DSB,
but could be a particularly relevant mechanism to facili-
tate CSR and VDJ. It has been shown that chromosomal
regions targeted by RAG or AID for DSBs are repos-
itioned and juxtaposed to deﬁned nuclear domains prior
to cleavage by their respective targeting enzymes (52,53).
It is intriguing to speculate that recombination (as
opposed to rejoining of each individual break) between
Nucleic Acids Research,2012, Vol.40, No. 4 1691these paired DSBs might be facilitated by XRCC4/XLF
DNA ‘bridging’ complexes that nucleate at each single
DSB that were physically in close proximity because of
nuclear repositioning prior cleavage.
We cannot address whether DNA-PKcs (green) or
XRCC4/XLF ﬁlaments localize to Ku-bound DNA ﬁrst.
However, cellular trafﬁcking and chromatin fractionation
experiments suggest that both XRCC4/XLF and
DNA-PKcs are independently targeted to Ku-bound
DNA although the DNA-PK holoenzyme stabilizes
XRCC4’s presence at sites of damage (50,49,54).
Implicating XRCC4/XLF complexes in an early stage
of c-NHEJ provides a mechanistic explanation for data
from Chu and colleagues who used an in vitro end
joining assay to demonstrate that end processing
requires XRCC4 (55). Of course, DNA-PK is also
required for regulation of end processing which it
mediates by its own autophosphorylation (9,56,57,58).
Here, we show that DNA-PK phosphorylation of the
C-terminal tails of XRCC4 or XLF disrupts ﬁlament sta-
bility and the ability to bridge DNA. We have depicted
this event as simpliﬁcation of the XRCC4/XLF bundle
over the break to a single ﬁlament (third panel) allowing
access to DNA-PKcs (green), and then associated with
XRCC4/DNA Ligase IV (red, only BRCT domains
depicted, bottom panel). It is also possible that this tran-
sition results in a simpler complex of XRCC4/XLF/DNA
Ligase IV (not associated with the ﬁlament) over the
break. Blocking phosphorylation of the XRCC4/XLF
ﬁlament radio-protects cells, perhaps by stabilizing the
XRCC4/XLF ﬁlament bundle and allowing c-NHEJ
more time to complete repair. These data suggest that
DNA-PK phosphorylation of XRCC4/XLF may be im-
portant either for transition from complexes that facilitate
bridging to complexes that mediate ligation or potentially
for complex dissociation.
Figure 5. A model of c-NHEJ. A space-ﬁlling model of c-NHEJ complex is presented. DNA is colored in yellow. XRCC4/XLF ﬁlaments are shown
in dark blue, XRCC4/XLF bundles are shown in grey. DNA-PKcs is colored light and dark green. Ku is colored pink and maroon. The BRCT
domains of DNA Ligase IV are shown in red, and the XRCC4 dimer associated with BRCTs is orange.
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